A phase I dose escalation and pharmacokinetic study of vatalanib (PTK787/ZK 222584) in combination with paclitaxel in patients with advanced solid tumors

2009 ◽  
Vol 66 (3) ◽  
pp. 441-448 ◽  
Author(s):  
E. Gabriela Chiorean ◽  
Srikar Malireddy ◽  
Anne E. Younger ◽  
David R. Jones ◽  
Mary-Jane Waddell ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Pharmacokinetic Study ◽  
Dose Escalation ◽  
Advanced Solid Tumors

scholarly journals A phase I dose-escalation and pharmacokinetic study of enzastaurin and erlotinib in patients with advanced solid tumors

2011 ◽  
Vol 69 (4) ◽  
pp. 1013-1020 ◽  
Author(s):  
Sukhmani K. Padda ◽  
Yelena Krupitskaya ◽  
Laveena Chhatwani ◽  
George A. Fisher ◽  
Alexander D. Colevas ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Pharmacokinetic Study ◽  
Dose Escalation ◽  
Advanced Solid Tumors

scholarly journals Phase I dose escalation and pharmacokinetic study of oral enzastaurin (LY317615) in advanced solid tumors

2010 ◽  
Vol 101 (10) ◽  
pp. 2193-2199 ◽  
Author(s):  
Toru Mukohara ◽  
Shunji Nagai ◽  
Minori Koshiji ◽  
Kenichi Yoshizawa ◽  
Hironobu Minami
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Pharmacokinetic Study ◽  
Dose Escalation ◽  
Advanced Solid Tumors

scholarly journals Phase I Dose-Escalation and Pharmacokinetic Study of Dasatinib in Patients with Advanced Solid Tumors

2009 ◽  
Vol 15 (19) ◽  
pp. 6232-6240 ◽  
Author(s):  
George D. Demetri ◽  
Patricia Lo Russo ◽  
Iain R.J. MacPherson ◽  
Ding Wang ◽  
Jeffrey A. Morgan ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Pharmacokinetic Study ◽  
Dose Escalation ◽  
Advanced Solid Tumors

A phase I, dose escalation, pharmacodynamic, pharmacokinetic, and food-effect study of α2 integrin inhibitor E7820 in patients with advanced solid tumors

2016 ◽  
Vol 34 (3) ◽  
pp. 329-337 ◽  
Author(s):  
B. Milojkovic Kerklaan ◽  
S. Slater ◽  
M. Flynn ◽  
A. Greystoke ◽  
P. O. Witteveen ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Dose Escalation ◽  
Food Effect ◽  
Effect Study ◽  
Advanced Solid Tumors ◽  
Integrin Inhibitor

A phase I and pharmacokinetic study of paclitaxel poliglumex and cisplatin in patients with advanced solid tumors

2008 ◽  
Vol 63 (5) ◽  
pp. 903-910 ◽  
Author(s):  
Claire F. Verschraegen ◽  
Keith Skubitz ◽  
Adil Daud ◽  
Andrzej P. Kudelka ◽  
Ian Rabinowitz ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Pharmacokinetic Study ◽  
Advanced Solid Tumors

scholarly journals Phase I and Pharmacokinetic Study of Sequential Paclitaxel and Trabectedin Every 2 Weeks in Patients with Advanced Solid Tumors

2010 ◽  
Vol 16 (9) ◽  
pp. 2656-2665 ◽  
Author(s):  
Quincy Chu ◽  
Alain Mita ◽  
Bahram Forouzesh ◽  
Anthony W. Tolcher ◽  
Gary Schwartz ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Pharmacokinetic Study ◽  
Advanced Solid Tumors

scholarly journals Phase I and pharmacokinetic study of lexatumumab (HGS-ETR2) given every 2 weeks in patients with advanced solid tumors

2010 ◽  
Vol 21 (2) ◽  
pp. 376-381 ◽  
Author(s):  
H.A. Wakelee ◽  
A. Patnaik ◽  
B.I. Sikic ◽  
M. Mita ◽  
N.L. Fox ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Pharmacokinetic Study ◽  
Advanced Solid Tumors

Dose-Finding Phase I Clinical and Pharmacokinetic Study of Orally Administered Irinotecan in Patients with Advanced Solid Tumors

2006 ◽  
Vol 12 (12) ◽  
pp. 3774-3781 ◽  
Author(s):  
Isa E.L.M. Kuppens ◽  
Eric Dansin ◽  
Henk Boot ◽  
Celine Feger ◽  
Sylvia Assadourian ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Pharmacokinetic Study ◽  
Dose Finding ◽  
Advanced Solid Tumors
Sign in / Sign up

Export Citation Format

Share Document